Welcome to Arctom, sign up to enjoy up to
20% OFF
+1 800-931-7508
[email protected]
Search in Small Molecules
Search in Biologics
Structure Search
Sign in
Register
Cart - 0 item(s)
$0.00
Your shopping cart is empty!
Chemistry
Alcohols and Derivatives
Amines and Anilines
Amino Acids and Derivatives
Boronic Acids and Esters
Carbonyl Compounds
Halides
Heterocycles
Nitrogen Compounds
Phosphorus Compounds
Sulfur Compounds
Functional Material
Oxygen Compounds
Chemistry
Inhibitors
Anti-infection
Apoptosis
Autophagy
Cell Cycle/DNA Damage
Natural Products
Alkaloids
Amino acid
Anthraquinones
Cerebrosides
Chalcones
Coumarins
Diterpenoids
Flavonoids
Iridoids
Lignans
Lipids
Miscellaneous
Monoterpenoids
Other terpenes
Phenols
Phenylpropanoids
Quinones
Saccharides
Sesquiterpenoids
Steroids
Tetraterpenoids
Thiophenes
Triterpenoids
Xanthones
Polyphenols
Stibene glucosides
Oligose
Anthocyanins
Miscellaneous
Chromones
Terpenoids
Indoles
Procyanidins
Aliphatics
Botanical Cyclopeptides
ADCs
Toxins
Linkers
Payloads with linkers
Miscellaneous
Antibodies
Primary Antibodies
Secondary Antibodies
Multiplex IHC
Material Science
Others
Catalysts
Rare Earth Metal Compounds
Transition Metal Compounds
Other
Chiral Compound
Chiral Reagents/Auxiliary
Lithium Reagent
Grignard Reagents
Silylating Reagents
Organosilicon Compounds
Inorganic Salts
Inorganic Compounds
Coupling Reagent
Oxidant
Reductant
Sugars
Rock
Tin Compounds
Our clients include world's top universities and pharmaceutical organizations
Valneva SE
Tuesday, February 18, 2025
Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook
Regeneron Pharmaceuticals
Tuesday, February 18, 2025
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
Sanofi
Tuesday, February 18, 2025
Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid
Galapagos NV
Monday, February 17, 2025
Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification and 13D filing from Tang Capital.
World Cornea Congress
Thursday, March 20, 2025
Washington DC, USA
16th European Paediatric Neurology Society Congress
Tuesday, July 8, 2025
Munich, Germany
Nature
Sunday, February 16, 2025
Ambient-pressure superconductivity onset above 40 K in (La,Pr)3Ni2O7 films
Nature
Sunday, February 16, 2025
Characterization of single neurons reprogrammed by pancreatic cancer
Lancet
Friday, February 14, 2025
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study
Lancet
Friday, February 14, 2025
Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial
Do Vitamin Supplements Cause Cancer? - Oncology Support Network
How Fast Does Leukemia Develop? - Oncology Support Network
How Long Do Lymph Node Biopsy Results Take? - Oncology Support Network
Does Tia Mowry Have Cancer? - Oncology Support Network
KYORIN Pharmaceutical
Monday, February 17, 2025
KYORIN and Cyrano Therapeutics Enter into an Option Agreement for CYR-064 for the Treatment of Post-Viral Loss of Smell in Japan
Innate Pharma
Monday, February 17, 2025
Innate Pharma announces U.S. FDA granted Breakthrough Therapy Designation to lacutamab for relapsed or refractory Sézary Syndrome
Hanmi Pharmaceutical
Monday, February 17, 2025
Hanmi Pharmaceutical Confirms ‘Complete Remission’ in Phase 1/2 Study of Its Innovative Selective CCR4 Antagonist
EyePoint Pharmaceuticals
Monday, February 17, 2025
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nature Medicine
Thursday, February 13, 2025
Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial
Nature
Tuesday, February 11, 2025
Learning produces an orthogonalized state machine in the hippocampus
Nature
Tuesday, February 11, 2025
Transcriptional adaptation upregulates utrophin in Duchenne muscular dystrophy
Nature
Tuesday, February 11, 2025
Transcriptomic neuron types vary topographically in function and morphology
Can An MRI Tell If A Tumor Is Benign? - Oncology Support Network
Stem Cell Therapy: Restore Your Skin at the Cellular Level #glowfromwithin #lifealtering
6
6
Lung Cancer Show Ever
57
57
Simple Health: 28 weeks pregnant & diagnosed with stage 3 breast cancer
Sumitomo Dainippon Pharma
Monday, February 17, 2025
Sumitomo Pharma Selected as Highest Rating A-List Company by CDP in the Category of Climate Change in CDP 2024
Chugai Pharmaceutical
Sunday, February 16, 2025
Galderma’s Announcement Regarding NEMLUVIO (EC Approval for the Treatment of Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis)
Exelixis
Saturday, February 15, 2025
Exelixis Announces Final Five-Year Follow-up Results from CheckMate -9ER Trial Evaluating CABOMETYX® (cabozantinib) in Combination with Opdivo® (nivolumab) in Patients with Advanced Kidney Cancer at ASCO GU 2025
GlaxoSmithKline
Saturday, February 15, 2025
Penmenvy, GSK’s 5-in-1 meningococcal vaccine, approved by US FDA to help protect against MenABCWY
Nature
Tuesday, February 11, 2025
Topological segregation of stress sensors along the gut crypt–villus axis
Nature
Tuesday, February 11, 2025
A metagenomic ‘dark matter’ enzyme catalyses oxidative cellulose conversion
Nature
Tuesday, February 11, 2025
UM171 glues asymmetric CRL3–HDAC1/2 assembly to degrade CoREST corepressors
Nature
Tuesday, February 11, 2025
Global engineering effects of soil invertebrates on ecosystem functions
1
1
The Gene Therapy That Saved Javier’s Life! #GeneTherapy #WiskottAldrichSyndrome
The Gene Therapy That Saved Javier’s Life – A Medical Revolution!
CRISPR Explained: Unlocking Genetic Secrets#shortsfeed #shortsvideo #shorts
4
4
CheckMate 274: additional survival outcomes of adjuvant nivolumab in MIBC
Sarepta Therapeutics
Friday, February 14, 2025
Sarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit Facility
Benitec Biopharma
Friday, February 14, 2025
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
Arcturus Therapeutics
Friday, February 14, 2025
European Commission Approves CSL and Arcturus Therapeutics’ KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine
Benitec Biopharma
Friday, February 14, 2025
Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference
Nature
Tuesday, February 11, 2025
Genetic architecture in Greenland is shaped by demography, structure and selection
Nature
Tuesday, February 11, 2025
Macrophages protect against sensory axon loss in peripheral neuropathy
Nature
Tuesday, February 11, 2025
Manipulation of the altermagnetic order in CrSb via crystal symmetry
Nature
Tuesday, February 11, 2025
Shielding Pt/γ-Mo2N by inert nano-overlays enables stable H2 production
32
32
15th Muscat International Oncology Conference: Advancing Cancer Care
019 Viral Gene Therapy: Augment Your DNA
What Does A Tumor On The Spine Feel Like? - Oncology Support Network
Can EEG Detect Brain Tumor? - Oncology Support Network
Not More
Show More
loading...